A Phase I Dose Escalation Study of High-Dose Thiotepa, Melphalan and Carboplatin (TMCb) Followed by Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients With Solid Tumors and Hematologic Malignancies

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1702239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search